Evidence map›Paper›PMID 31003534›Full record

ReviewAntioxidants (Basel, Switzerland)2019

The Role of Isothiocyanates as Cancer Chemo-Preventive, Chemo-Therapeutic and Anti-Melanoma Agents.

Melina Mitsiogianni, Georgios Koutsidis, Nikos Mavroudis, Dimitrios T Trafalis, Sotiris Botaitis, Rodrigo Franco, Vasilis Zoumpourlis, Tom Amery, Alex Galanis, Aglaia Pappa and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 1 pooled it
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 1 synthesis or guideline pooled it, 143 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Isothiocyanate-Rich Essential Oil ofPlants (Basel, Switzerland) · 2026
    Article
  8. Review
  9. Article
  10. Review
  11. Chicago Sky Blue 6B modulates MAPK/NF-kB pathway in rat knee osteoarthritis.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Frontiers in nutrition · 2025
    Review

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Melina MitsiogianniDepartment of Applied Sciences, Northumbria University, Newcastle Upon Tyne NE1 8ST, UK. melina.mitsiogianni@northumbria.ac.uk.
Georgios KoutsidisDepartment of Applied Sciences, Northumbria University, Newcastle Upon Tyne NE1 8ST, UK. georgios.koutsidis@northumbria.ac.uk.
Nikos MavroudisDepartment of Food and Nutritional Sciences, University of Reading, Reading RG6 6AP, UK. nikos.mavroudis@reading.ac.uk.
Dimitrios T TrafalisLaboratory of Pharmacology, Unit of Clinical Pharmacology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece. dtrafal@med.uoa.gr.
Sotiris BotaitisSecond Department of Surgery, Democritus University of Thrace, 68100 Alexandroupolis, Greece. smpotait@med.duth.gr.
Rodrigo FrancoRedox Biology Centre, University of Nebraska-Lincoln, Lincoln, NE 68588, USA. rodrigo.franco@unl.edu.
Vasilis ZoumpourlisInstitute of Biology, Medicinal Chemistry and Biotechnology, National Hellenic Research Foundation, 11635 Athens, Greece. vzub@eie.gr.
Tom AmeryThe Watrercress Company / The Wasabi Company, Waddock, Dorchester, Dorset DT2 8QY, UK. tom.amery@thewatercresscompany.com.
Alex GalanisDepartment of Molecular Biology and Genetics, Democritus University of Thrace, 68100 Alexandroupolis, Greece. agalanis@mbg.duth.gr.
Aglaia PappaDepartment of Molecular Biology and Genetics, Democritus University of Thrace, 68100 Alexandroupolis, Greece. apappa@mbg.duth.gr.
Mihalis I PanayiotidisDepartment of Applied Sciences, Northumbria University, Newcastle Upon Tyne NE1 8ST, UK. m.panagiotidis@northumbria.ac.uk.
Democritus University of Thrace · GRNorthumbria University · GBNational and Kapodistrian University of Athens · GRNational Hellenic Research Foundation · GRUniversity of Nebraska–Lincoln · USUniversity of Reading · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many studies have shown evidence in support of the beneficial effects of phytochemicals in preventing chronic diseases, including cancer. Among such phytochemicals, sulphur-containing compounds (e.g., isothiocyanates (ITCs)) have raised scientific interest by exerting unique chemo-preventive properties against cancer pathogenesis. ITCs are the major biologically active compounds capable of mediating the anticancer effect of cruciferous vegetables. Recently, many studies have shown that a higher intake of cruciferous vegetables is associated with reduced risk of developing various forms of cancers primarily due to a plurality of effects, including (i) metabolic activation and detoxification, (ii) inflammation, (iii) angiogenesis, (iv) metastasis and (v) regulation of the epigenetic machinery. In the context of human malignant melanoma, a number of studies suggest that ITCs can cause cell cycle growth arrest and also induce apoptosis in human malignant melanoma cells. On such basis, ITCs could serve as promising chemo-therapeutic agents that could be used in the clinical setting to potentiate the efficacy of existing therapies.

Indexed as

cell cyclechemo-therapycruciferous vegetablesglucosinolatesgrowth arrestisothiocyanatesmalignant melanomaskin cancer

Identifiers

PMID31003534
PMCPMC6523696
OpenAlexW2937883230

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.